Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.8299
-0.0002 (-0.02%)
Sep 16, 2026, 8:54 AM EDT - Market open
Genenta Science Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 |
Selling, General & Admin | 3.9 | 4.15 | 4.4 | 4.68 | 4.95 | 4.9 | 4.86 | 5.06 | 5.26 | 5.66 |
Research & Development | 2.7 | 3.46 | 4.23 | 4.52 | 4.81 | 4.7 | 4.59 | 5.53 | 6.47 | 7.05 |
Operating Expenses | 6.6 | 7.62 | 8.63 | 9.2 | 9.76 | 9.61 | 9.45 | 10.59 | 11.73 | 12.71 |
Operating Income | -6.6 | -7.62 | -8.63 | -9.2 | -9.76 | -9.61 | -9.45 | -10.59 | -11.73 | -12.71 |
Interest & Investment Income | 0.62 | 0.62 | 0.09 | 0.08 | 0.61 | 0.44 | 0.26 | 0.29 | 0.31 | 0.26 |
Currency Exchange Gain (Loss) | -0.55 | -0.53 | -0.52 | -0.14 | 0.24 | 0.16 | 0.09 | -0.06 | -0.22 | 0.05 |
Other Non Operating Income (Expenses) | - | -0.09 | 0.36 | 0.44 | - | 0.09 | 0.18 | 0.09 | -0 | 0.02 |
EBT Excluding Unusual Items | -6.53 | -7.62 | -8.7 | -8.81 | -8.91 | -8.92 | -8.92 | -10.29 | -11.65 | -12.39 |
Pretax Income | -6.53 | -7.62 | -8.7 | -8.81 | -8.91 | -8.92 | -8.92 | -10.29 | -11.65 | -12.39 |
Net Income | -6.53 | -7.62 | -8.7 | -8.81 | -8.91 | -8.92 | -8.92 | -10.29 | -11.65 | -12.39 |
Net Income to Common | -6.53 | -7.62 | -8.7 | -8.81 | -8.91 | -8.92 | -8.92 | -10.29 | -11.65 | -12.39 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 20 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Shares Change (YoY) | 7.86% | 4.74% | 1.60% | 0.96% | 0.31% | 0.21% | 0.11% | 0.06% | - | - |
EPS (Basic) | -0.33 | -0.40 | -0.47 | -0.48 | -0.49 | -0.49 | -0.49 | -0.56 | -0.64 | -0.68 |
EPS (Diluted) | -0.33 | -0.40 | -0.47 | -0.48 | -0.49 | -0.49 | -0.49 | -0.56 | -0.64 | -0.68 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 |
Free Cash Flow | -6.88 | -8.29 | -9.71 | -7.98 | -6.24 | -5.97 | -5.69 | -8.45 | -11.22 | -11.84 |
Free Cash Flow Per Share | -0.35 | -0.43 | -0.52 | -0.43 | -0.34 | -0.33 | -0.31 | -0.46 | -0.62 | -0.65 |
EBITDA | -6.58 | -7.58 | -8.59 | -9.16 | -9.72 | -9.56 | -9.41 | -10.55 | -11.69 | -12.68 |
D&A For EBITDA | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 |
EBIT | -6.6 | -7.62 | -8.63 | -9.2 | -9.76 | -9.61 | -9.45 | -10.59 | -11.73 | -12.71 |